Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction
暂无分享,去创建一个
Yugang Dong | Jingjing Zhao | Bin Dong | Ruicong Xue | Chen Liu | Yuzhong Wu | Xin He | Dexi Wu | Zexuan Wu | Yuanyuan Zhou | Jiangui He
[1] D. Kass,et al. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial. , 2018, JACC. Heart failure.
[2] S. Solomon,et al. Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials , 2018, Circulation.
[3] K. Rentsch,et al. Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function , 2017, European journal of heart failure.
[4] K. Anstrom,et al. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). , 2016, Circulation. Heart failure.
[5] Volkmar Falk,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[6] B. Mullan,et al. Volume Overload Profiles in Patients With Preserved and Reduced Ejection Fraction Chronic Heart Failure: Are There Differences? A Pilot Study. , 2016, JACC. Heart failure.
[7] K. Fukuda,et al. Effect of Estimated Plasma Volume Reduction on Renal Function for Acute Heart Failure Differs Between Patients With Preserved and Reduced Ejection Fraction , 2015, Circulation. Heart failure.
[8] M. Vaduganathan,et al. Hemoconcentration-guided diuresis in heart failure. , 2014, American Journal of Medicine.
[9] D. Kass,et al. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. , 2014, Circulation research.
[10] Adrian F Hernandez,et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. , 2013, JAMA.
[11] C. Parikh,et al. Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. , 2013, Journal of the American College of Cardiology.
[12] M. Dupont,et al. Lack of concordance in defining worsening renal function by rise in creatinine vs rise in cystatin C. , 2013, Congestive heart failure.
[13] R. Nishimura,et al. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. , 2012, Journal of the American College of Cardiology.
[14] Adrian F Hernandez,et al. Diuretic strategies in patients with acute decompensated heart failure. , 2011, The New England journal of medicine.
[15] G. Navis,et al. A re-appraisal of volume status and renal function impairment in chronic heart failure: combined effects of pre-renal failure and venous congestion on renal function , 2011, Heart Failure Reviews.
[16] S. Kimmel,et al. Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival , 2010, Circulation.
[17] D. Mancini,et al. Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions. , 2008, The American journal of cardiology.
[18] V. Roger,et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.
[19] A. Boyle,et al. Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate. , 2006, Journal of cardiac failure.
[20] C. O'connor,et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. , 2004, American heart journal.
[21] W. Suki. DIURETIC RESISTANCE? , 1979, The Lancet.
[22] O. Aalen. Nonparametric Inference for a Family of Counting Processes , 1978 .
[23] L. J. Wei,et al. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions , 1989 .